Drug trials in children: Problems and the way forward

British Journal of Clinical Pharmacology

Volumn 49, Issue 2, 2000, Pages 93-97

  Conroy, Sharon ^a,b   McIntyre, John ^a   Choonara, Imti ^a   Stephenson, Terence ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Licensed; Medicines in children; Off label; Paediatric drug therapy; Unlicensed

Indexed keywords

BLOOD SAMPLING; CHILD; DRUG FORMULATION; DRUG INDUSTRY; DRUG SCREENING; DRUG TOXICITY; ETHICS; PRIORITY JOURNAL; SHORT SURVEY;

CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DRUG APPROVAL; DRUG THERAPY; EUROPEAN UNION; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033984630     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00125.x     Document Type: Short Survey

References (35)

1. 1 Licensing medicines for children. London. British Paediatric Association, May 1996.
2. 2 Turner S, Gill A, Nunn T, Choonara I, Hewitt B. Use of 'off-label' and unlicensed drugs in paediatric intensive care unit. Lancet 1996; 347: 549-550.
3. 3 Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed drug use on paediatric wards. Br Med J 1998; 316: 343-345.
4. 4 Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: F142-F145.
5. 5 Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the U.K. Paediatric Perinatal Drug Ther 1997; 1: 52-55.
6. 6 Appleton R, Sweency A, Choonara I, Robson J, Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status cpilepticus. Dev Med Child Neurol 1995; 37: 682-688.
7. 7 Hughes J. Gill A, Leach HJ, et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994; 83: 1194-1199.
8. 8 Note for guidance on clinical investigation of medicinal products in children. London. Medicines Control Agency, 1997.
9. 9 Choonara I, Dunne J. Licensing of medicines. Arch Dis Child 1998; 78: 402-403.
10. 10 Collier J. Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications. Br J Clin Pharmacol 1999; 48: 5-8.
11. 11 Impicciatore P, Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999; 48: 15-18.
12. 12 Guidelines for the ethical conduct of medical research involving children. London. British Paediatric Association 1992.
13. 13 Choonara I, Lawrence A, Michalkiewicz A, Bowhay A, Ratcliffe J. Morphine metabolism in neonates and infants. Br J Clin Pharmacol 1992; 34: 434-437.
14. 14 Burtin P, Jacqz-Aigrain E, Girard P, et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther 1994; 56: 615-625.
15. 15 Hain RDW, Hardcastle A, Pinkerton CR, Aheme GW. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal Quid of children. Arch Dis Child 1999; 80(Suppl 1): A9.
16. 16 Hughes J, Gill AM, Mulhearn H, Powell H, Choonara I. Steady state plasma concentrations of midazolam in critically ill infants and children. Ann Pharmacother 1996; 30: 27-30.
17. 17 Barrett DA, Barker DP, Rutter N, Pawula M, Shaw PN. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. Br J Clin Pharmacol 1996; 41: 531-537.
18. 18 Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42: 407-410.
19. 19 Fisher E, Siemes H, Pund R, Wittfoht W, Nau H. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms; abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia 1992; 33: 165-171.
20. 20 Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med 1960; 262: 787-794.
21. 21 Penna A, Buchanan N. Paracetamol poisoning in children and hcpatotoxicity. Br J Clin Pharmacol 1991; 32: 143-149.
22. 22 Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 1989; 36: 39-46.
23. 2 breath test. Dev Pharmacol Ther 1989; 12: 90-95.
24. 24 Parker AC. Preston T, Heaf D, Kitteringham NR, Choonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Clin Pharmacol 1994; 38: 573-576.
25. 25 Parker AC, Pritchard P. Preston T. Smyth RL, Choonara I. Enhanced drug metabolism in young children with cystic fibrosis. Arch Dis Child 1997; 77: 239-241.
26. 26 Parker AC, Pritchard P, Preston T, Choonara I. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol 1998; 45: 176-178.
27. 27 Wrighton SA, Stevens JC. The Human Hepatic Cytochromes P450 involved in drug metabolism. Crit Rev Toxicology 1992; 22: 1-21.
28. 28 Breitkrcutz J, Wessel T, Boos J. Dosage forms for peroral drug administration to children. Paediatric and Perinatal Drug Therapy 1999; 3: 25-33.
29. 29 Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986; 77: 848-849.
30. 30 Roberts R, Maldonado S. FDA Center for Drug Evaluation and Research (CDER) Pediatric Plan and New Regulations. Drug Information Journal 1996; 30: 1125-1127.
31. 31 Nahata MC. Licensing of Medicines for Children in the USA. Paediatric Perinatal Drug Ther 1997; 1: 50-51.
32. 32 Moore P. Children are not small adults. Lancet 1998; 352: 630.
33. 33 Kearns G. The Paediatric Pharmacology Research Unit Network. Proof of Concept. Paediatric and Perinatal Drug Therapy 1999; 3: 9-14.
34. 34 Brown EG, Choonara I. The safety of medicines used in children. Int J Pharmaceut Med 1998; 12: 285-288.
35. 35 Norris E, Marzouk O, Nunn AJ, McIntyre J, Choonara I. Respiratory depression in children receiving diazepam for acute seizures-a prospective study. Dev Med Child Neurol 1999; 41: 340-343.